zenodoopen
Risk of bias in assessed studies for LSR: Antiplatelet agents for the treatment of adults with COVID-19
<p>This is our RoB2 excel sheet, in which detailled information about our risk of bias rating can be found. This concerns the outcomes of studies included in our LSR Antiplatelet agents for the treatment of adults with COVID-19. The first version is published before publication of the review.</p>
ShareScore
40/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 4
- Access
- 16
- Reuse readiness
- 8
- Engagement
- 4